Humanized tau antibody
US9657091B2 · kind B2 · utility
5Cited by
15References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 15, 2013 |
| Grant date | May 23, 2017 |
| Priority date | — |
| Expiry date | Mar 15, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods and compositions for the therapeutic and diagnostic use in the treatment of diseases and disorders which are caused by or associated with neurofibrillary tangles. In particular, the invention relates to humanized antibodies, which specifically recognize and bind to phosphorylated pathological protein tau-conformers to methods and compositions involving said antibodies for the therapeutic and diagnostic use in the treatment of tauopathies including Alzheimer's Disease (AD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.